Back to Search
Start Over
Secondary plasma cell leukaemia treated with single agent venetoclax.
- Source :
-
British journal of haematology [Br J Haematol] 2020 Aug; Vol. 190 (4), pp. e242-e245. Date of Electronic Publication: 2020 Jun 11. - Publication Year :
- 2020
- Subjects :
- Aged
Antibodies, Monoclonal therapeutic use
Antineoplastic Agents pharmacology
Antineoplastic Agents, Immunological therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Bridged Bicyclo Compounds, Heterocyclic pharmacology
Chromosomes, Human, Pair 11 genetics
Chromosomes, Human, Pair 11 ultrastructure
Chromosomes, Human, Pair 14 genetics
Chromosomes, Human, Pair 14 ultrastructure
Combined Modality Therapy
Drug Resistance, Neoplasm
Female
Humans
Leukemia, Plasma Cell blood
Leukemia, Plasma Cell genetics
Leukemia, Plasma Cell therapy
Multiple Myeloma drug therapy
Neoplasm Proteins antagonists & inhibitors
Plasma Cells
Plasmapheresis
Progression-Free Survival
Proto-Oncogene Proteins c-bcl-2 antagonists & inhibitors
Sulfonamides pharmacology
Translocation, Genetic
Antineoplastic Agents therapeutic use
Bridged Bicyclo Compounds, Heterocyclic therapeutic use
Leukemia, Plasma Cell drug therapy
Neoplasms, Second Primary drug therapy
Sulfonamides therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2141
- Volume :
- 190
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- British journal of haematology
- Publication Type :
- Report
- Accession number :
- 32525557
- Full Text :
- https://doi.org/10.1111/bjh.16858